HK Stock MarketDetailed Quotes
01877 JUNSHI BIO
- 11.760
- +0.920+8.49%
Market Closed Apr 30 16:08 CST
11.59BMarket Cap-5198P/E (TTM)
12.140High10.940Low3.93MVolume11.280Open10.840Pre Close45.49MTurnover1.79%Turnover RatioLossP/E (Static)985.69MShares29.95052wk High1.53P/B2.58BFloat Cap9.17052wk Low--Dividend TTM219.30MShs Float97.150Historical High--Dividend LFY11.07%Amplitude9.170Historical Low11.582Avg Price200Lot Size--Div YieldTTM--Div Yield LFY
JUNSHI BIO Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 6.93%-2.49B | ---- | ---- | ---- | -351.40%-2.68B | ---- | ---- | ---- | 64.50%-592.65M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | -62.95%-99.43M | ---- | ---- | ---- | -96.97%-61.02M | ---- | ---- | ---- | -52.77%-30.98M |
| Attributable subsidiary (profit) loss | ---- | -14.85%60.48M | ---- | ---- | ---- | 46.57%71.03M | ---- | ---- | ---- | 1,173.67%48.46M |
| Impairment and provisions: | --0 | 580.25%149.8M | --0 | --0 | --0 | 65.51%22.02M | --0 | --0 | --0 | 196.85%13.31M |
| -Impairmen of inventory (reversal) | ---- | 325.13%93.42M | ---- | ---- | ---- | 61.02%21.97M | ---- | ---- | ---- | 222.85%13.65M |
| -Impairment of trade receivables (reversal) | ---- | 49,865.96%23.48M | ---- | ---- | ---- | 113.74%47K | ---- | ---- | ---- | -234.12%-342K |
| -Other impairments and provisions | ---- | --32.9M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Revaluation surplus: | --0 | 1,504.76%144.94M | --0 | --0 | --0 | --9.03M | --0 | --0 | --0 | --0 |
| -Other fair value changes | ---- | 1,504.76%144.94M | ---- | ---- | ---- | --9.03M | ---- | ---- | ---- | ---- |
| Asset sale loss (gain): | --0 | -373.71%-127.94M | --0 | --0 | --0 | -79,538.24%-27.01M | --0 | --0 | --0 | -67.31%34K |
| -Loss (gain) from sale of subsidiary company | ---- | -351.49%-130.24M | ---- | ---- | ---- | ---28.85M | ---- | ---- | ---- | ---- |
| -Loss (gain) on sale of property, machinery and equipment | ---- | 24.92%2.3M | ---- | ---- | ---- | 5,305.88%1.84M | ---- | ---- | ---- | -95.37%34K |
| Depreciation and amortization: | --0 | 3.26%303.22M | --0 | --0 | --0 | 11.84%293.65M | --0 | --0 | --0 | 73.46%262.56M |
| -Depreciation | ---- | 1.66%288.45M | ---- | ---- | ---- | 10.28%283.73M | ---- | ---- | ---- | 72.30%257.29M |
| -Amortization of intangible assets | ---- | 48.89%14.77M | ---- | ---- | ---- | 88.45%9.92M | ---- | ---- | ---- | 158.60%5.27M |
| Financial expense | ---- | -1.24%29.01M | ---- | ---- | ---- | 34.52%29.37M | ---- | ---- | ---- | -25.72%21.83M |
| Exchange Loss (gain) | ---- | 103.19%2.66M | ---- | ---- | ---- | -615.53%-83.51M | ---- | ---- | ---- | -48.12%16.2M |
| Special items | ---- | -116.61%-11M | ---- | ---- | ---- | -12.51%66.24M | ---- | ---- | ---- | 616.34%75.72M |
| Operating profit before the change of operating capital | --0 | 13.47%-2.04B | --0 | --0 | --0 | -1,169.62%-2.36B | --0 | --0 | --0 | 87.50%-185.52M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | 96.29%-5.06M | ---- | ---- | ---- | 11.90%-136.39M | ---- | ---- | ---- | 7.28%-154.82M |
| Accounts receivable (increase)decrease | ---- | -127.31%-265.34M | ---- | ---- | ---- | 254.43%971.48M | ---- | ---- | ---- | -22.71%-629.06M |
| Accounts payable increase (decrease) | ---- | 115.67%75.16M | ---- | ---- | ---- | -165.31%-479.57M | ---- | ---- | ---- | 11.52%734.29M |
| prepayments (increase)decrease | ---- | -133.43%-110.54M | ---- | ---- | ---- | --330.62M | ---- | ---- | ---- | ---- |
| Special items for working capital changes | ---- | --5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from business operations | --0 | -26.72%-2.11B | --0 | --0 | --0 | -230.80%-1.67B | --0 | --0 | --0 | 66.32%-504.29M |
| Other taxs | ---- | 192.46%99.05M | ---- | ---- | ---- | 22.15%-107.13M | ---- | ---- | ---- | -7,989.89%-137.61M |
| Special items of business | ---- | 21,381.57%224.91M | ---- | ---- | ---- | 100.39%1.05M | ---- | ---- | ---- | -3,415.84%-269.18M |
| Net cash from operations | 47.72%-376.58M | -13.50%-2.01B | -48.92%-1.66B | -168.45%-1.23B | -226.26%-720.25M | -176.57%-1.78B | -106.90%-1.12B | -1,046.91%-457.5M | 42.75%570.43M | 57.17%-641.9M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | ---- | 74.30%101.62M | ---- | 156.11%60.83M | ---- | 88.19%58.3M | ---- | 26.45%23.75M | ---- | 52.77%30.98M |
| Loan receivable (increase) decrease | ---- | 322.69%1.95M | ---- | 367.53%1.95M | ---- | 76.92%-877K | ---- | 72.96%-730K | ---- | -177.19%-3.8M |
| Decrease in deposits (increase) | ---- | 190.92%26.41M | ---- | 883.88%4.52M | ---- | -1,329.07%-29.05M | ---- | 136.37%459K | ---- | -129.77%-2.03M |
| Sale of fixed assets | ---- | 409,600.00%4.1M | 3,252.10%22.12K | 2,100.00%22K | ---- | -90.91%1K | -24.40%660 | 0.00%1K | ---- | --11K |
| Purchase of fixed assets | -68.97%-212.29M | -50.88%-578.01M | -112.80%-604.66M | -40.22%-201.02M | -29.43%-125.64M | 50.40%-383.1M | 56.99%-284.14M | 70.84%-143.36M | 57.04%-97.07M | -37.78%-772.35M |
| Purchase of intangible assets | ---- | -2,246.01%-254.57M | ---- | 94.89%-414K | ---- | 25.15%-10.85M | ---- | 13.87%-8.1M | ---- | 45.74%-14.5M |
| Sale of subsidiaries | ---- | --40.65M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | --2.22M | ---- | --2.22M | ---- | ---- |
| Recovery of cash from investments | -62.77%150M | 493,962.86%1.21B | 1,224.63%1.21B | 1,218.27%1.2B | --402.85M | -99.96%245K | -70.06%91M | -70.06%91.25M | ---- | 533,186.79%565.28M |
| Cash on investment | 96.87%-25.06M | -1,294.93%-1.46B | -585.48%-1.34B | -529.32%-1.23B | -804.12%-800M | 93.94%-104.5M | 82.31%-195.48M | 80.32%-195.36M | 67.55%-88.48M | -841.60%-1.73B |
| Other items in the investment business | -52.92%14.08M | --12.7M | 101.96%85.4M | --500K | 192.30%29.91M | ---- | 631.95%42.29M | ---- | 12.43%10.23M | 8.37%40.65M |
| Net cash from investment operations | 85.13%-73.27M | -90.84%-892.42M | -88.79%-653.83M | 30.30%-160.22M | -181.13%-492.87M | 75.14%-467.62M | 76.22%-346.34M | 80.42%-229.88M | 64.19%-175.32M | -169.49%-1.88B |
| Net cash before financing | 62.92%-449.85M | -29.62%-2.91B | -58.35%-2.32B | -101.98%-1.39B | -407.03%-1.21B | 11.09%-2.24B | 26.67%-1.46B | 38.95%-687.37M | 539.35%395.11M | -14.84%-2.52B |
| Cash flow from financing activities | ||||||||||
| New borrowing | 1,299.67%1.28B | 16.27%977.1M | -21.55%602.68M | -48.89%214.73M | --91.3M | 68.07%840.36M | 53.64%768.21M | --420.11M | ---- | 33.60%500M |
| Refund | -100.00%-30M | -323.92%-480.92M | -3,792.29%-389.23M | -2,233.38%-116.67M | -200.00%-15M | 85.70%-113.45M | 98.74%-10M | 90.62%-5M | ---5M | -97.63%-793.33M |
| Issuing shares | ---- | -96.00%152.6M | ---- | ---- | ---- | 77.30%3.81B | ---- | -99.21%16.98M | ---- | -55.64%2.15B |
| Interest paid - financing | ---- | -49.61%-38.23M | ---- | -31.32%-18M | ---- | -13.70%-25.55M | ---- | 39.74%-13.71M | ---- | 51.40%-22.47M |
| Dividends paid - financing | -55.26%-13.64M | ---- | -63.18%-27.7M | ---- | -81.44%-8.79M | ---- | 38.53%-16.97M | ---- | 52.06%-4.84M | ---- |
| Absorb investment income | ---- | -99.22%3M | -60.81%155.59M | -99.21%3M | -59.05%155.59M | -56.87%386M | -81.29%396.98M | --380M | --380M | --895M |
| Issuance expenses and redemption of securities expenses | ---- | -0.30%-29.64M | ---- | -349.84%-2.75M | ---- | 0.41%-29.56M | ---- | 97.84%-612K | ---- | 91.21%-29.68M |
| Other items of the financing business | -23.77%-14.43M | 142.78%97.14M | 135.06%99.84M | 153.16%139.81M | 10.12%-11.66M | -568.64%-227.07M | -825.45%-284.8M | -1,401.34%-262.97M | -48.42%-12.97M | -52.49%-33.96M |
| Net cash from financing operations | 476.88%1.22B | -85.33%681.04M | -48.30%441.19M | -58.84%220.12M | -40.80%211.45M | 74.18%4.64B | -51.79%853.4M | -73.63%534.8M | 1,996.00%357.19M | -39.60%2.67B |
| Effect of rate | 111.75%1.25M | -91.82%7.55M | -79.92%21.54M | -54.39%25.1M | -834.70%-10.64M | 497.25%92.27M | 1,055.69%107.23M | 395.97%55.03M | -76.10%1.45M | 49.25%-23.23M |
| Net Cash | 176.19%771.24M | -192.76%-2.23B | -268.69%-1.86B | -665.69%-1.17B | -234.30%-1.01B | 1,580.33%2.4B | -111.84%-503.19M | -116.91%-152.58M | 833.85%753.75M | -93.56%142.83M |
| Begining period cash | -37.00%3.78B | 71.12%6B | 71.12%6B | 71.12%6B | 71.12%6B | 3.53%3.5B | 3.53%3.5B | 3.53%3.5B | 3.53%3.5B | 178.82%3.38B |
| Cash at the end | -8.73%4.55B | -37.00%3.78B | 37.99%4.14B | 42.46%4.85B | 17.06%4.98B | 71.12%6B | -4.64%3B | -20.18%3.41B | 29.74%4.26B | 3.53%3.5B |
| Cash balance analysis | ||||||||||
| Cash and cash equivalent balance | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
| Auditor | -- | Huapu Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Huapu Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Huapu Tianjian Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg